Terms: = Uterine cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
160 results:
1. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
2. Aggressive precursor B cell ALL of cervix with obstructive uropathy.
Bahadur A; Mundhra R; Gill P; Singh A
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38569729
[TBL] [Abstract] [Full Text] [Related]
3. Enhancing Human Papillomavirus Vaccination Rates through Better Knowledge? Insights from a Survey among German Medical Students.
Aksoy C; Reimold P; Schumann A; Schneidewind L; Karschuck P; Flegar L; Leitsmann M; Heers H; Huber J; Zacharis A; Ihrig A
Urol Int; 2024; 108(2):153-158. PubMed ID: 38246131
[TBL] [Abstract] [Full Text] [Related]
4. Specific Pathology Features Enrich Selection of Endometrial Carcinomas for POLE Testing.
Keyhanian K; Han L; Howitt BE; Longacre T
Am J Surg Pathol; 2024 Mar; 48(3):292-301. PubMed ID: 38062789
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis.
Hwang JH; Kim B
J Gynecol Oncol; 2024 Jan; 35(1):e9. PubMed ID: 37857564
[TBL] [Abstract] [Full Text] [Related]
6. Laparoscopic versus open radical hysterectomy in FIGO 2018 early-stage cervical adenocarcinoma: Long-term survival outcomes after propensity score matching.
Yin Z; Cui Z; Kang S; Ji M; Li D; Chen B; Zhan X; Li W; Liu P; Chen C
J Obstet Gynaecol Res; 2023 Dec; 49(12):2849-2859. PubMed ID: 37658744
[TBL] [Abstract] [Full Text] [Related]
7. The intersection of race/ethnicity and socioeconomic status: inequalities in breast and cervical cancer mortality in 20,665,005 adult women from the 100 Million Brazilian Cohort.
Góes EF; Guimarães JMN; Almeida MDCC; Gabrielli L; Katikireddi SV; Campos AC; Matos SMA; Patrão AL; Oliveira Costa AC; Quaresma M; Leyland AH; Barreto ML; Dos-Santos-Silva I; Aquino EML
Ethn Health; 2024 Jan; 29(1):46-61. PubMed ID: 37642313
[TBL] [Abstract] [Full Text] [Related]
8. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with uterine Fibroids.
Thao V; Moriarty JP; Stewart EA; Borah BJ
J Minim Invasive Gynecol; 2023 Oct; 30(10):813-819. PubMed ID: 37286130
[TBL] [Abstract] [Full Text] [Related]
9. Endocervical curettage for diagnosing high-grade squamous intraepithelial lesions or worse in women with type 3 transformation zone lesions: a retrospective, observational study.
Wei B; Li Q; Seery S; Qiao Y; Jiang Y
BMC Womens Health; 2023 May; 23(1):245. PubMed ID: 37161558
[TBL] [Abstract] [Full Text] [Related]
10. LINC01589 serves as a potential tumor-suppressor and immune-related biomarker in endometrial cancer: A review.
Chen R; An J; Wang Y; Yang L; Lin Q; Wang Y
Medicine (Baltimore); 2023 Apr; 102(15):e33536. PubMed ID: 37058060
[TBL] [Abstract] [Full Text] [Related]
11. Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
Suzuki Y; Chen L; Hou JY; St Clair CM; Khoury-Collado F; de Meritens AB; Matsuo K; Melamed A; Hershman DL; Wright JD
Obstet Gynecol; 2023 May; 141(5):979-987. PubMed ID: 37023446
[TBL] [Abstract] [Full Text] [Related]
12. Diagnosis of hydatidiform moles using circulating gestational trophoblasts isolated from maternal blood.
Ravn K; Hatt L; Singh R; Schelde P; Hansen ES; Vogel I; Uldbjerg N; Niemann I; Sunde L
Placenta; 2023 Apr; 135():7-15. PubMed ID: 36889013
[TBL] [Abstract] [Full Text] [Related]
13. Clinical outcome analysis of intramural myoma greater than 8 cm in diameter removed during caesarean section: a retrospective study.
Shi C; Chen J; Chen A
BMC Womens Health; 2023 Feb; 23(1):60. PubMed ID: 36774454
[TBL] [Abstract] [Full Text] [Related]
14. Influencing factors and risk prediction model for cervical cancer recurrence.
Li J; Luo J; Liu G; Yan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1711-1720. PubMed ID: 36748382
[TBL] [Abstract] [Full Text] [Related]
15. The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma: A Pooled Data Analysis.
Patrich T; Wang Y; Elshaikh MA; Zhu S; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Taunk NK; Chino J; Russo AL; Lea JS; Lee LJ; Albuquerque KV; Hathout L
Am J Clin Oncol; 2023 Mar; 46(3):114-120. PubMed ID: 36625449
[TBL] [Abstract] [Full Text] [Related]
16. RESOLVE-DWI-based deep learning nomogram for prediction of normal-sized lymph node metastasis in cervical cancer: a preliminary study.
Qian W; Li Z; Chen W; Yin H; Zhang J; Xu J; Hu C
BMC Med Imaging; 2022 Dec; 22(1):221. PubMed ID: 36528577
[TBL] [Abstract] [Full Text] [Related]
17. Cervical cancer screening and outcomes for women under 25 years of age in Belgium: a 10-year nationwide study.
Desimpel F; Declercq S; Makar A
Eur J Cancer Prev; 2023 Mar; 32(2):163-170. PubMed ID: 36134615
[TBL] [Abstract] [Full Text] [Related]
18. Cervical cancer management in Zimbabwe (2019-2020).
Zibako P; Tsikai N; Manyame S; Ginindza TG
PLoS One; 2022; 17(9):e0274884. PubMed ID: 36129898
[TBL] [Abstract] [Full Text] [Related]
19. Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer.
Sun W; Hang D; Han S; Fu S; Ma H; Dong X; Xu Y; Li N; Hu Z
Gene; 2022 Nov; 844():146824. PubMed ID: 35995117
[TBL] [Abstract] [Full Text] [Related]
20. Maternal and neonatal outcomes in women with a history of chemotherapy exposure: a population-based study of 8 million obstetric admissions.
Sorokine A; Czuzoj-Shulman N; Abenhaim HA
Arch Gynecol Obstet; 2023 Mar; 307(3):747-753. PubMed ID: 35523971
[TBL] [Abstract] [Full Text] [Related]
[Next]
